Secondary diabetes in children

Canadian Journal of Diabetes

Volumn 28, Issue 4, 2004, Pages 400-405

  Ho, Josephine ^a   Pacaud, Danièle ^a  

^a ALBERTA CHILDREN'S HOSPITAL   (Canada)

Author keywords

Cystic fibrosis; Pediatric; Post transplant; Secondary diabetes

Indexed keywords

BLOOD TRANSFUSION; CHEMOTHERAPY; CYSTIC FIBROSIS; DIABETES MELLITUS; HUMAN; ORGAN TRANSPLANTATION; PANCREAS INJURY; PEDIATRICS; REVIEW; RISK FACTOR;

EID: 28844480941     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. American Diabetes Association Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2004;27(suppl 1):S5-S10.
2. Dacou-Voutetakis C, Palis J, Haidas S, et al. Abnormal glucose tolerance in children with acute leukemia. Effect of induction chemotherapy including L-asparaginase. Am J Pediatr Hematol Oncol. 1983;5:139-146.
3. Hjelmesaeth J, Midtvedt K, Jenssen T, et al. Insulin resistance after renal transplantation: impact of immunosuppressive and antihypertensive therapy. Diabetes Care. 2001;24:2121-2126.
4. Hjelmesaeth J, Jenssen T, Hagen M, et al. Determinants of insulin secretion after renal transplantation. Metabolism. 2003;52:573-578.
5. Land VJ, Sutow WW, Fernbach DJ, et al. Toxicity of L-asparginase in children with advanced leukemia. Cancer. 1972;30:339-347.
6. Pui CH, Burghen GA, Bowman WP, et al. Risk factors for hyperglycemia in children with leukemia receiving L-asparaginase and prednisone. J Paediatr. 1981;99:46-50.
7. Weir MR, Fink JC. Risk for posttransplant diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis. 1999;34:1-13.
8. Kalhan SC, Adam PA. Inhibitory effect of prednisone on insulin secretion in man: model for duplication of blood glucose concentration. J Clin Endocrinol Metab. 1975;41:600-610.
9. Traggiai C, Stanhope R, Nussey S, et al. Diabetes mellitus after bone marrow transplantation during childhood. Med Pediatr Oncol. 2003;40:128-129.
10. Levy P, Menzelxhiu A, Paillot B, et al. Abdominal radiotherapy is a cause for chronic pancreatitis. Gastroenterology. 1993;105:903-909.
11. Kasiske BL, Snyder JJ, Gilbertson D, et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant. 2003;3:178-185.
12. Cosio FG, Pesavento TE, Osei K, et al. Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int. 2001;59:732-737.
13. Johny KV, Nampoory MR, Costandi JN, et al. High incidence of post-transplant diabetes mellitus in Kuwait. Diabetes Res Clin Pract. 2002;55:123-130.
14. al Asfari R, Hadidy S, Hadid I, et al. The prevalence of diabetes post kidney transplantation. Transplant Proc. 1999;31:3230.
15. Greenspan LC, Gitelman SE, Leung MA, et al. Increased incidence in post-transplant diabetes mellitus in children: a case-control analysis. Pediatr Nephrol. 2002;17:1-5.
16. Al Uzri A, Stablein DM, Cohn A. Posttransplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation. 2001;72:1020-1024.
17. Depczynski B, Daly B, Campbell LV, et al. Predicting the occurrence of diabetes mellitus in recipients of heart transplants. Diabet Med. 2000;17:15-19.
18. Nieuwenhuis MG, Kirkels JH. Predictability and other aspects of post-transplant diabetes mellitus in heart transplant recipients. J Heart Lung Transplant. 2001;20:703-708.
19. Hathout EH, Chinnock RE, Johnston JK, et al. Pediatric posttransplant diabetes: data from a large cohort of pediatric heart-transplant recipients. Am J Transplant. 2003;3:994-998.
20. Steinmuller TH, Stockmann M, Bechstein WO, et al. Liver transplantation and diabetes mellitus. Exp Clin Endocrinol Diabetes. 2000;108:401-405.
21. Hirayama M, Azuma E, Kumamoto T, et al. Late-onset unilateral renal dysfunction combined with non-insulin-dependent diabetes mellitus and bronchial asthma following allogeneic bone marrow transplantation for acute lymphoblastic leukemia in a child. Bone Marrow Transplant. 1998;22:923-926.
22. Amin P, Shah S, Walker D, et al. Adverse metabolic and cardiovascular risk following treatment of acute lymphoblastic leukaemia in childhood; two case reports and a literature review. Diabet Med. 2001;18:849-853.
23. Taskinen M, Saarinen-Pihkala UM, Hovi L, et al. Impaired glucose tolerence and dyslipidaemia as late effects after bonemarrow transplantation in childhood. Lancet. 2000;356:993-997.
24. Hoffmeister PA, Storer BE, Sanders JE. Diabetes mellitus in long-term survivors of pediatric hematopoietic cell transplantation. J Pediatr Hematol Oncol. 2004;26:81-90.
25. Yoshida EM, Buczkowski AK, Sirrs SM, et al. Post-transplant diabetic ketoacidosis - a possible consequence of immunosuppression with calcineurin inhibiting agents: a case series. Transpl Int. 2000;13:69-72.
26. Gillette PC, Hill LL, Starling KA, et al. Transient diabetes mellitus secondary to L-asparaginase therapy in acute leukemia. J Paediatr. 1972;81:109-111.
27. Moran A, Milla C. Abnormal glucose tolerance in cystic fibrosis: why should patients be screened? J Pediatr. 2003;142:97-99.
28. Finkelstein SM, Wielinski CL, Elliot GR, et al. Diabetes mellitus associated with cystic fibrosis. J Pediatr. 1988;112:373-377.
29. Lanng S, Thorsteinsson B, Lund-Anderson C, et al. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr. 1994;83:72-77.
30. Cucinotta D, DeLuca F, Scoglio R, et al. Factors affecting diabetes mellitus onset in cystic fibrosis: evidence from a 10-year follow-up study. Acta Paediatr. 1999;88:389-393.
31. Moran A, Doherty L, Wang X, et al. Abnormal glucose metabolism in cystic fibrosis. J Pediatr. 1998;133:10-17.
32. Solomon MP, Wilson DC, Acorey M, et al. Glucose intolerance in children with cystic fibrosis. J Pediatr. 2003;142:128-132.
33. Chern JP, Lin KH, Lu MY, et al. Abnormal glucose tolerance in transfusion-dependent beta-thalassemic patients. Diabetes Care. 2001;24:850-854.
34. Cario H, Holl RW, Debatin KM, et al. Insulin sensitivity and beta-cell secretion in thalassaemia major with secondary haemochromatosis: assessment by oral glucose tolerance test. Eur J Pediatr. 2003;162:139-146.
35. Merkel PA, Simonson DC, Amiel SA, et al. Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion. N Engl J Med. 1958;318:809-814.
36. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2003;27(suppl 2):S1-S152.
37. Moran A, Hardin D, Rodman D, et al. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract. 1999;45:61-73.